MIT researchers developed a way to deliver RNA in a capsule that can be swallowed, which could make RNA vaccines easier to tolerate. It could also make it easier to deliver other kinds of therapeutic RNA or DNA directly to the digestive tract, to help treat gastrointestinal disorders.

By adding synergistic self-adjuvanting properties to Covid-19 RNA vaccines, MIT researchers showed they could significantly boost the immune response generated in mice.

Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.

This cohort study investigates the presence of COVID-19 vaccine mRNA in the expressed breast milk of lactating individuals who received the vaccination within 6 months after delivery.

A phase I clinical trial of an adjuvant personalized mRNA neoantigen vaccine, autogene cevumeran, in patients with pancreatic ductal carcinoma demonstrates that the vaccine can induce T cell activity that may correlate with delayed recurrence of disease.

A doctor who promoted COVID-19 vaccines is now calling for health authorities around the world to pause the ...

MIT Professor Xiao Wang's research is focused on developing tools that pinpoint where in a cell different types of messenger RNA are translated into proteins — information that can offer insight into how cells control their fate and what goes wrong in disease.

VERIFIED COVID-19 will remain and keep mutating, and therefore we need to be prepared with vaccines to deal with emerging variants. Researchers are

0 votes and 18 comments so far on Reddit

Positive trial results are generating excitement about the strategy

The recommendation is based on data which shows that primary vaccination with the adapted bivalent vaccines should give rise to a broad immune response in...

Bis jetzt 0 Votes und 13 Kommentare auf Reddit

CanSino Biologics has agreed with AstraZeneca to provide "contract development and manufacturing services" to support the Anglo-Swedish drugmaker's messenger...

The biopharmaceutical firm said it would pay Arcturus $200 million upfront in return for an exclusive licence to its next generation mRNA technology to...

It may seem like snail's pace compared to our COVID-19 vaccines, but the wheels are certainly turning in the development of a universal mRNA influenza vaccine. The latest has just entered trial, with many others at the same stage or even further along.

A $40 million investment will help several African manufacturers produce new messenger RNA vaccines on the continent where people were last in line to...

China's Stemirna Therapeutics said on Wednesday it had suspended work at a factory it had planned to use to manufacture its COVID-19 vaccine candidate that...

0 votes et 2 commentaires jusqu'à présent sur Reddit

Startup aims to bring a versatile, sustainable, and scalable RNA synthesis technology to market to unlock development of new RNA drugs, vaccines, and gene-editing therapies

Article URL: https://cen.acs.org/pharmaceuticals/vaccines/cancer-vaccines-RNA-Moderna-BioNTech/101/i20 Comments URL: https://news.ycombinator.com/item?id=36473792 Points: 2 # Comments: 0